WEYBOSSET RESEARCH & MANAGEMENT LLC - CALMARE THERAPEUTICS INC ownership

CALMARE THERAPEUTICS INC's ticker is CTTC and the CUSIP is 13126R102. A total of 1 filers reported holding CALMARE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
WEYBOSSET RESEARCH & MANAGEMENT LLC ownership history of CALMARE THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$8,000
-66.7%
200,0000.0%0.00%
-70.0%
Q2 2021$24,000
+9.1%
200,0000.0%0.01%
+11.1%
Q1 2021$22,000
+83.3%
200,0000.0%0.01%
+50.0%
Q4 2020$12,000
-20.0%
200,000
+23.9%
0.01%
-25.0%
Q3 2020$15,000
+50.0%
161,4000.0%0.01%
+33.3%
Q2 2020$10,000
-28.6%
161,4000.0%0.01%
-40.0%
Q1 2020$14,000
-48.1%
161,4000.0%0.01%
-28.6%
Q4 2019$27,000
+50.0%
161,4000.0%0.01%
+40.0%
Q3 2019$18,000
+12.5%
161,4000.0%0.01%
+11.1%
Q2 2019$16,000
+220.0%
161,4000.0%0.01%
+200.0%
Q1 2019$5,000
-44.4%
161,4000.0%0.00%
-50.0%
Q4 2018$9,000
-52.6%
161,4000.0%0.01%
-45.5%
Q3 2018$19,000
+18.8%
161,4000.0%0.01%
+10.0%
Q2 2018$16,000
+14.3%
161,400
+26.1%
0.01%
+25.0%
Q1 2018$14,000
+27.3%
128,000
+28.0%
0.01%
+14.3%
Q4 2017$11,000
+120.0%
100,000
+100.0%
0.01%
+133.3%
Q3 2017$5,0000.0%50,0000.0%0.00%0.0%
Q2 2017$5,000
-16.7%
50,0000.0%0.00%
-25.0%
Q1 2017$6,000
-40.0%
50,0000.0%0.00%
-42.9%
Q4 2016$10,000
+25.0%
50,0000.0%0.01%
+16.7%
Q3 2016$8,000
-33.3%
50,0000.0%0.01%
-33.3%
Q2 2016$12,000
+140.0%
50,000
+150.0%
0.01%
+125.0%
Q1 2016$5,000
+25.0%
20,0000.0%0.00%0.0%
Q4 2015$4,000
-20.0%
20,0000.0%0.00%0.0%
Q3 2015$5,000
+66.7%
20,000
+100.0%
0.00%
+100.0%
Q2 2015$3,00010,0000.00%
Other shareholders
CALMARE THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
WEYBOSSET RESEARCH & MANAGEMENT LLC 200,000$24,0000.01%
View complete list of CALMARE THERAPEUTICS INC shareholders